William A. Curran

Davis Polk is advising Novo Nordisk A/S on its $1.8 billion acquisition of Emisphere Technologies Inc. and related Eligen SNAC royalty stream obligations owed to MHR Fund Management LLC,…

Davis Polk advised Coloplast on its acquisition of Nine Continents Medical, an early stage company pioneering an implantable tibial nerve stimulation treatment for over-active bladder. The…

Davis Polk advised Duddell Street Acquisition Corp. on its $175 million initial public offering of 17,500,000 units. Each unit had an initial offering price of $10 and consists of one Class…

Davis Polk advised the joint book runners in connection with the initial public offering of 57,500,000 units of Bluescape Opportunities Acquisition Corp. for aggregate proceeds of $575…

Davis Polk is advising Alliance Data Systems on its acquisition of Bread, a technology-driven digital payments company. The transaction is valued at estimated consideration of $450…

Davis Polk advised the initial purchasers in connection with the offering by Promigas S.A. E.S.P. and its subsidiary Gases del Pacífico S.A.C., as co-issuers, of $120 million aggregate…

Davis Polk advised Arcos Dorados Holdings Inc. in connection with the exchange of approximately $131.5 million aggregate principal amount of its 6.625% senior notes due 2023 for its 5.785%…

Davis Polk advised the joint book-running managers on an SEC-registered offering by LYB International Finance III, LLC, a wholly owned subsidiary of LyondellBasell Industries N.V., of $500…

Davis Polk advised the underwriters in connection with the offering of $1.25 billion aggregate principal amount of 1.125% bonds due October 7, 2030 issued by the Province of Ontario. The…

Davis Polk advised VG Acquisition Corp. on its $480 million initial public offering of 48,000,000 units. Each unit had an initial offering price of $10 and consists of one Class A ordinary…